These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 7502369)

  • 1. Secondary acute myeloblastic leukemia in a child with acute lymphoblastic leukemia treated with epipodophyllotoxins.
    Ozbek N; Cetin M; Tuncer AM; Yetgin S
    Turk J Pediatr; 1995; 37(3):279-82. PubMed ID: 7502369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
    Pui CH; Ribeiro RC; Hancock ML; Rivera GK; Evans WE; Raimondi SC; Head DR; Behm FG; Mahmoud MH; Sandlund JT
    N Engl J Med; 1991 Dec; 325(24):1682-7. PubMed ID: 1944468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone.
    Ohshima A; Miura I; Chubachi A; Hashimoto K; Nimura T; Utsumi S; Takahashi N; Hayashi Y; Seto M; Ueda R; Miura AB
    Am J Hematol; 1996 Dec; 53(4):264-6. PubMed ID: 8948668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typhlitis in a patient with acute lymphoblastic leukemia prior to the administration of chemotherapy.
    Paulino AF; Kenney R; Forman EN; Medeiros LJ
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):348-51. PubMed ID: 7978054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins.
    Pui CH; Relling MV; Behm FG; Hancock ML; Boyett JM; Raimondi SC; Krance RA; Mahmoud HH; Ribeiro RC; Sandlund JT
    Leukemia; 1995 Oct; 9(10):1680-4. PubMed ID: 7564509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
    Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The successive presence of acute lymphoblastic leukemia, Hodgkin's disease and acute myeloblastic leukemia in a female patient].
    del Potro E; Espinola Guedes G; Martínez R; Alvarez A; Díaz Mediavilla J; Martín C; Villegas A; Espinós D
    Rev Clin Esp; 1991 Jun; 189(1):21-2. PubMed ID: 1924921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia.
    Cetin M; Hiçsönmez G; Tuncer AM; Kansu E; Canpynar H
    Exp Hematol; 1996 Aug; 24(10):1191-4. PubMed ID: 8765493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.
    Sung WJ; Kim DH; Sohn SK; Kim JG; Baek JH; Jeon SB; Moon JH; Ahn BM; Lee KB
    Jpn J Clin Oncol; 2005 Oct; 35(10):612-6. PubMed ID: 16172175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
    Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
    Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
    RamaChandran S; Ariffin H
    Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of refractory acute leukaemia with aclacinomycin A.
    Rowe JM; Chang AY; Bennett JM
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():47-8. PubMed ID: 2627607
    [No Abstract]   [Full Text] [Related]  

  • 14. Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.
    Felix CA; Winick NJ; Negrini M; Bowman WP; Croce CM; Lange BJ
    Cancer Res; 1993 Jul; 53(13):2954-6. PubMed ID: 8319201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.
    Horstmann MA; Hassenpflug WA; zur Stadt U; Escherich G; Janka G; Kabisch H
    Haematologica; 2005 Dec; 90(12):1701-3. PubMed ID: 16330449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results and complications of induction treatment of acute leukemia in children. A personal series of 79 cases (1988-1989)].
    Regaieg R; Bertrand Y; Mardini R; Manel AM; Berthier JC; Magaud JP; Charrin C; Barbe G; Souillet G; Philippe N
    Pediatrie; 1992; 47(1):47-53. PubMed ID: 1337777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia.
    Relling MV; Yanishevski Y; Nemec J; Evans WE; Boyett JM; Behm FG; Pui CH
    Leukemia; 1998 Mar; 12(3):346-52. PubMed ID: 9529129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia.
    Kaya Z; Gursel T; Bakkaloglu SA; Kocak U; Atasever T; Oktar SO
    Pediatr Hematol Oncol; 2007 Jun; 24(4):257-67. PubMed ID: 17613868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multiface morphology of acute leukemia.
    Mittelman M; Floru S; Djaldetti M
    Haematologia (Budap); 1993; 25(3):205-13. PubMed ID: 8119633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.